“CVS Caremark Corp. (CVS), the largest provider of prescription drugs in the U.S., forecast 2013 profit that topped analysts’ estimates as it benefits from new pharmacy customers.
Adjusted profit next year will be $3.84 a share to $3.98 a share, Woonsocket, Rhode Island-based CVS said today in a statement. The average estimate of 21 analysts in a Bloomberg survey was $3.81.”
If you enjoy the content at iBankCoin, please follow us on Twitter
